|
|
||||||||
Department of 1Pediatrics and 2Physiology, New York Medical College, Valhalla, New York 10595; and LDM Associates, San Jose, California 95126
Submitted 6 May 2003 ; accepted in final form 7 August 2003
Postural tachycardia syndrome (POTS) is defined by orthostatic intolerance associated with abnormal upright tachycardia. Some patients have defective peripheral vasoconstriction and increased calf blood flow. Others have increased peripheral arterial resistance and decreased blood flow. In 14 POTS patients (1319 yr) evenly subdivided among low-flow POTS (LFP) and high-flow POTS (HFP) we tested the hypothesis that myogenic, venoarteriolar, and reactive hyperemic responses are abnormal. We used venous occlusion plethysmography to measure calf venous pressure and blood flow in the supine position and when the calf was lowered by 40 cm to evoke myogenic and venoarteriolar responses and during venous hypertension by 40-mmHg occlusion to evoke the venoarteriolar response. We measured calf reactive hyperemia with plethysmography and cutaneous laser-Doppler flowmetry. Baseline blood flow in LFP was reduced compared with HFP and control subjects (0.8 ± 0.2 vs. 4.4 ± 0.5 and 2.7 ± 0.4 ml · min1 · 100 ml1) but increased during leg lowering (1.2 ± 0.5 ml · min1 · 100 ml1) while decreasing in the others. Baseline peripheral arterial resistance was increased in LFP and decreased in HFP compared with control subjects (39 ± 13 vs. 15 ± 3 and 22 ± 5 mmHg · ml1 · 100 ml · min) but decreased to 29 ± 13 mmHg · ml1 · 100 ml · min in LFP during venous hypertension. Resistance increased in the other groups. Maximum calf hyperemic flow and cutaneous flow were similar in all subjects. The duration of hyperemic blood flow was curtailed in LFP compared with either control or HFP subjects (plethysmographic time constant = 20 ± 2 vs. 29 ± 4 and 28 ± 4 s; cutaneous time constant = 60 ± 25 vs. 149 ± 53 s in controls). Local blood flow regulation in low-flow POTS is impaired.
myogenic vasoconstriction; venoarteriolar vasoconstriction; autonomic vasoconstriction
This article has been cited by other articles:
![]() |
S. Carew, J. Cooke, M. O'Connor, T. Donnelly, A. Costelloe, C. Sheehy, and D. Lyons What is the optimal duration of tilt testing for the assessment of patients with suspected postural tachycardia syndrome? Europace, May 1, 2009; 11(5): 635 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stewart, A. J. Ocon, D. Clarke, I. Taneja, and M. S. Medow Defects in Cutaneous Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Production in Postural Tachycardia Syndrome Hypertension, May 1, 2009; 53(5): 767 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stewart, I. Taneja, J. Glover, and M. S. Medow Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H466 - H473. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stewart, M. S. Medow, C. T. Minson, and I. Taneja Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2161 - H2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kooijman, M. de Hoog, G. A. Rongen, H. J. M. van Kuppevelt, P. Smits, and M. T. E. Hopman Local vasoconstriction in spinal cord-injured and able-bodied individuals J Appl Physiol, September 1, 2007; 103(3): 1070 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Garland, S. R. Raj, B. K. Black, P. A. Harris, and D. Robertson The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome Neurology, August 21, 2007; 69(8): 790 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Garland, B. K. Black, P. A. Harris, and D. Robertson Dopamine-beta-hydroxylase in postural tachycardia syndrome Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H684 - H690. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Vinik and D. Ziegler Diabetic Cardiovascular Autonomic Neuropathy Circulation, January 23, 2007; 115(3): 387 - 397. [Full Text] [PDF] |
||||
![]() |
J. M. Stewart, L. D. Montgomery, J. L. Glover, and M. S. Medow Changes in regional blood volume and blood flow during static handgrip Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H215 - H223. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jacob, E. M. Garland, F. Costa, C. M. Stein, H.-G. Xie, R. M. Robertson, I. Biaggioni, and D. Robertson {beta}2-Adrenoceptor Genotype and Function Affect Hemodynamic Profile Heterogeneity in Postural Tachycardia Syndrome Hypertension, March 1, 2006; 47(3): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stewart, M. S. Medow, J. L. Glover, and L. D. Montgomery Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H665 - H673. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okazaki, Q. Fu, E. R. Martini, R. Shook, C. Conner, R. Zhang, C. G. Crandall, and B. D. Levine Vasoconstriction during venous congestion: effects of venoarteriolar response, myogenic reflexes, and hemodynamics of changing perfusion pressure Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1354 - R1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Garland, R. Winker, S. M. Williams, L. Jiang, K. Stanton, D. W. Byrne, I. Biaggioni, I. Cascorbi, J. A. Phillips III, P. A. Harris, et al. Endothelial NO Synthase Polymorphisms and Postural Tachycardia Syndrome Hypertension, November 1, 2005; 46(5): 1103 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stewart and L. D. Montgomery Regional blood volume and peripheral blood flow in postural tachycardia syndrome Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1319 - H1327. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |